Annexon Inc (ANNX)

Annexon Inc (ANNX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $726M; returns 1 day -1.6%, 1 week +10.0%, 1 year +23.0%.

Annexon Inc. (ANNX) is a clinical-stage biopharmaceutical company focused on developing a new class of complement medicines that inhibit the classical complement pathway, specifically the C1q component, to treat severe autoimmune, neurodegenerative, and ophthalmic disorders.

Groups ANNX belongs to

• Biotechnology
• Biopharmaceutical
• Clinical Stage Biopharma
• Healthcare
• Pharmaceuticals
• Autoimmune Diseases
• Neuroscience
• Monoclonal Antibodies
• Ophthalmology
• Rare Diseases
• Neurological Disorders

ANNX financial model: income statement, cash flow and balance sheet